Vucic D - Search Results

1

Ubiquitination in the regulation of inflammatory cell death and cancer.

Cockram PE, Kist M, Prakash S, Chen SH, Wertz IE, Vucic D. Cockram PE, et al. Among authors: vucic d. Cell Death Differ. 2021 Feb;28(2):591-605. doi: 10.1038/s41418-020-00708-5. Epub 2021 Jan 11. Cell Death Differ. 2021. PMID: 33432113 Free PMC article. Review.

2

Ubiquitin ligases in cancer: ushers for degradation.

Newton K, Vucic D. Newton K, et al. Among authors: vucic d. Cancer Invest. 2007 Sep;25(6):502-13. doi: 10.1080/07357900701508041. Cancer Invest. 2007. PMID: 17882664 Review.

3

IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.

Varfolomeev E, Blankenship JW, Wayson SM, Fedorova AV, Kayagaki N, Garg P, Zobel K, Dynek JN, Elliott LO, Wallweber HJ, Flygare JA, Fairbrother WJ, Deshayes K, Dixit VM, Vucic D. Varfolomeev E, et al. Among authors: vucic d. Cell. 2007 Nov 16;131(4):669-81. doi: 10.1016/j.cell.2007.10.030. Cell. 2007. PMID: 18022362 Free article.

4

Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death.

Vucic D, Dixit VM, Wertz IE. Vucic D, et al. Nat Rev Mol Cell Biol. 2011 Jun 23;12(7):439-52. doi: 10.1038/nrm3143. Nat Rev Mol Cell Biol. 2011. PMID: 21697901 Review.

5

Characterization of ML-IAP protein stability and physiological role in vivo.

Varfolomeev E, Moradi E, Dynek JN, Zha J, Fedorova AV, Deshayes K, Fairbrother WJ, Newton K, Le Couter J, Vucic D. Varfolomeev E, et al. Among authors: vucic d. Biochem J. 2012 Nov 1;447(3):427-36. doi: 10.1042/BJ20121103. Biochem J. 2012. PMID: 22853455

6

IAP family of cell death and signaling regulators.

Silke J, Vucic D. Silke J, et al. Among authors: vucic d. Methods Enzymol. 2014;545:35-65. doi: 10.1016/B978-0-12-801430-1.00002-0. Methods Enzymol. 2014. PMID: 25065885 Review.

7

Ubiquitination in disease pathogenesis and treatment.

Popovic D, Vucic D, Dikic I. Popovic D, et al. Among authors: vucic d. Nat Med. 2014 Nov;20(11):1242-53. doi: 10.1038/nm.3739. Epub 2014 Nov 6. Nat Med. 2014. PMID: 25375928 Review.

8

Ubiquitination profiling identifies sensitivity factors for IAP antagonist treatment.

Varfolomeev E, Izrael-Tomasevic A, Yu K, Bustos D, Goncharov T, Belmont LD, Masselot A, Bakalarski CE, Kirkpatrick DS, Vucic D. Varfolomeev E, et al. Among authors: vucic d. Biochem J. 2015 Feb 15;466(1):45-54. doi: 10.1042/BJ20141195. Biochem J. 2015. PMID: 25423073

9

Cellular IAP proteins and LUBAC differentially regulate necrosome-associated RIP1 ubiquitination.

de Almagro MC, Goncharov T, Newton K, Vucic D. de Almagro MC, et al. Among authors: vucic d. Cell Death Dis. 2015 Jun 25;6(6):e1800. doi: 10.1038/cddis.2015.158. Cell Death Dis. 2015. PMID: 26111062 Free PMC article.

10

RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury.

Newton K, Dugger DL, Maltzman A, Greve JM, Hedehus M, Martin-McNulty B, Carano RA, Cao TC, van Bruggen N, Bernstein L, Lee WP, Wu X, DeVoss J, Zhang J, Jeet S, Peng I, McKenzie BS, Roose-Girma M, Caplazi P, Diehl L, Webster JD, Vucic D. Newton K, et al. Among authors: vucic d. Cell Death Differ. 2016 Sep 1;23(9):1565-76. doi: 10.1038/cdd.2016.46. Epub 2016 May 13. Cell Death Differ. 2016. PMID: 27177019 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

123 results

Search Page